Table of Contents
Executive Summary
1 Industry Overview of Drugs of Abuse Testing
1.1 Definition of Drugs of Abuse Testing
1.2 Drugs of Abuse Testing Segment by Type
1.2.1 Global Drugs of Abuse Testing Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Psychostimulants
1.2.3 Narcotic
1.2.4 Hallucinogens
1.2.5 Sedatives
1.2.6 Others
1.3 Drugs of Abuse Testing Segment by Applications
1.3.1 Global Drugs of Abuse Testing Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Forensic Laboratories
1.3.5 Others
1.4 Global Drugs of Abuse Testing Overall Market
1.4.1 Global Drugs of Abuse Testing Revenue (2014-2025)
1.4.2 Global Drugs of Abuse Testing Production (2014-2025)
1.4.3 North America Drugs of Abuse Testing Status and Prospect (2014-2025)
1.4.4 Europe Drugs of Abuse Testing Status and Prospect (2014-2025)
1.4.5 China Drugs of Abuse Testing Status and Prospect (2014-2025)
1.4.6 Japan Drugs of Abuse Testing Status and Prospect (2014-2025)
1.4.7 Southeast Asia Drugs of Abuse Testing Status and Prospect (2014-2025)
1.4.8 India Drugs of Abuse Testing Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Drugs of Abuse Testing
2.3 Manufacturing Process Analysis of Drugs of Abuse Testing
2.4 Industry Chain Structure of Drugs of Abuse Testing
3 Development and Manufacturing Plants Analysis of Drugs of Abuse Testing
3.1 Capacity and Commercial Production Date
3.2 Global Drugs of Abuse Testing Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Drugs of Abuse Testing
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Drugs of Abuse Testing Production and Capacity Analysis
4.2 Drugs of Abuse Testing Revenue Analysis
4.3 Drugs of Abuse Testing Price Analysis
4.4 Market Concentration Degree
5 Drugs of Abuse Testing Regional Market Analysis
5.1 Drugs of Abuse Testing Production by Regions
5.1.1 Global Drugs of Abuse Testing Production by Regions
5.1.2 Global Drugs of Abuse Testing Revenue by Regions
5.2 Drugs of Abuse Testing Consumption by Regions
5.3 North America Drugs of Abuse Testing Market Analysis
5.3.1 North America Drugs of Abuse Testing Production
5.3.2 North America Drugs of Abuse Testing Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Drugs of Abuse Testing Import and Export
5.4 Europe Drugs of Abuse Testing Market Analysis
5.4.1 Europe Drugs of Abuse Testing Production
5.4.2 Europe Drugs of Abuse Testing Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Drugs of Abuse Testing Import and Export
5.5 China Drugs of Abuse Testing Market Analysis
5.5.1 China Drugs of Abuse Testing Production
5.5.2 China Drugs of Abuse Testing Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Drugs of Abuse Testing Import and Export
5.6 Japan Drugs of Abuse Testing Market Analysis
5.6.1 Japan Drugs of Abuse Testing Production
5.6.2 Japan Drugs of Abuse Testing Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Drugs of Abuse Testing Import and Export
5.7 Southeast Asia Drugs of Abuse Testing Market Analysis
5.7.1 Southeast Asia Drugs of Abuse Testing Production
5.7.2 Southeast Asia Drugs of Abuse Testing Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Drugs of Abuse Testing Import and Export
5.8 India Drugs of Abuse Testing Market Analysis
5.8.1 India Drugs of Abuse Testing Production
5.8.2 India Drugs of Abuse Testing Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Drugs of Abuse Testing Import and Export
6 Drugs of Abuse Testing Segment Market Analysis (by Type)
6.1 Global Drugs of Abuse Testing Production by Type
6.2 Global Drugs of Abuse Testing Revenue by Type
6.3 Drugs of Abuse Testing Price by Type
7 Drugs of Abuse Testing Segment Market Analysis (by Application)
7.1 Global Drugs of Abuse Testing Consumption by Application
7.2 Global Drugs of Abuse Testing Consumption Market Share by Application (2014-2019)
8 Drugs of Abuse Testing Major Manufacturers Analysis
8.1 Quest Diagnostics
8.1.1 Quest Diagnostics Drugs of Abuse Testing Production Sites and Area Served
8.1.2 Quest Diagnostics Product Introduction, Application and Specification
8.1.3 Quest Diagnostics Drugs of Abuse Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 F. Hoffmann La-Roche
8.2.1 F. Hoffmann La-Roche Drugs of Abuse Testing Production Sites and Area Served
8.2.2 F. Hoffmann La-Roche Product Introduction, Application and Specification
8.2.3 F. Hoffmann La-Roche Drugs of Abuse Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Siemens
8.3.1 Siemens Drugs of Abuse Testing Production Sites and Area Served
8.3.2 Siemens Product Introduction, Application and Specification
8.3.3 Siemens Drugs of Abuse Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Thermo Fisher Scientific
8.4.1 Thermo Fisher Scientific Drugs of Abuse Testing Production Sites and Area Served
8.4.2 Thermo Fisher Scientific Product Introduction, Application and Specification
8.4.3 Thermo Fisher Scientific Drugs of Abuse Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Alere
8.5.1 Alere Drugs of Abuse Testing Production Sites and Area Served
8.5.2 Alere Product Introduction, Application and Specification
8.5.3 Alere Drugs of Abuse Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Shimadzu
8.6.1 Shimadzu Drugs of Abuse Testing Production Sites and Area Served
8.6.2 Shimadzu Product Introduction, Application and Specification
8.6.3 Shimadzu Drugs of Abuse Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Laboratory Corporation of America
8.7.1 Laboratory Corporation of America Drugs of Abuse Testing Production Sites and Area Served
8.7.2 Laboratory Corporation of America Product Introduction, Application and Specification
8.7.3 Laboratory Corporation of America Drugs of Abuse Testing Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Drugs of Abuse Testing Market
9.1 Global Drugs of Abuse Testing Market Trend Analysis
9.1.1 Global Drugs of Abuse Testing Market Size (Volume and Value) Forecast 2019-2025
9.2 Drugs of Abuse Testing Regional Market Trend
9.2.1 North America Drugs of Abuse Testing Forecast 2019-2025
9.2.2 Europe Drugs of Abuse Testing Forecast 2019-2025
9.2.3 China Drugs of Abuse Testing Forecast 2019-2025
9.2.4 Japan Drugs of Abuse Testing Forecast 2019-2025
9.2.5 Southeast Asia Drugs of Abuse Testing Forecast 2019-2025
9.2.6 India Drugs of Abuse Testing Forecast 2019-2025
9.3 Drugs of Abuse Testing Market Trend (Product Type)
9.4 Drugs of Abuse Testing Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Drugs of Abuse Testing Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
【掲載企業】
Quest Diagnostics、F. Hoffmann La-Roche、Siemens、Thermo Fisher Scientific、Alere、Shimadzu、Laboratory Corporation of America
【免責事項】
https://www.globalresearch.jp/disclaimer